Summary
Perrigo, founded in 1887, is a leading manufacturer of generic over-the-counter healthcare products and supplier of infant formulas for the store-brand market. Perrigo’s private-label consumer products encompass a variety of cold/allergy, gastrointestinal, first aid, motion sickness, vitamin, smoking cessation, and other remedies. The company has a market cap of approximately $4 billion after divesting its RX pharmaceutical business in 2021. Headquartered in Dublin, Ireland, Perrigo has approximately 10,000 employees.
Subscribe to Yahoo Finance Plus Essential for full access
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
Source: finance.yahoo.com
Related posts:
Cathie Wood's New Venture Fund Offers Access to Hard-to-Trade Assets for Just $500
3 Magnificent Stocks That I'm "Never" Selling
Warren Buffett Just Sent Out a Deafening Warning Signal to the Market. 3 Things Investors Should Do.
Jeremy Siegel says there's a silver lining to the current bank crisis — making him more optimistic a...
Carl Icahn Slashes His Stake in Occidental Petroleum